Paper
Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: a prospective cross-over drug-drug interaction study.
Published Apr 1, 2011 · J. M. van der Bol, W. Loos, F. D. de Jong
European journal of cancer
18
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Omeprazole 40 mg does not alter the pharmacokinetics and toxicities of irinotecan, making it safe to administer during a 3-weekly single agent irinotecan schedule.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···